Own the scientific narrative
before it exists.
MSLs, R&D, ClinOps, and Pharmacovigilance teams now map every KOL and DOL, detect emerging trends in real time, and accelerate clinical timelines — all on one predictive intelligence layer wired to 95K+ injectors and live social velocity.
Legacy academic KOL lists become real-time Digital Opinion Leaders with predictive innovation signals.
Scientific affairs stops curating yesterday’s publication lists and starts acting on live behavior — posts, congresses, trial participation, and peer graphs, all fused into a single, governed intelligence layer.
- Legacy academic KOL lists
- Static publication-based scoring
- Quarterly congress debriefs
- Reactive pharmacovigilance review
- Real-time Digital Opinion Leaders
- 6-dimensional live influence score
- Predictive innovation signals
- Proactive AE & off-label surveillance
Four scientific functions. One living knowledge graph.
MSL, R&D, ClinOps, and PV each operate on the same KOL graph, the same signal stream, and the same ontology — with surfaces tuned to their work.
KOL mapping & competitor poaching
Every KOL scored on a six-dimensional influence model — publications, congresses, peer graph, patient reach, payer affinity, and live social velocity. Filter poachable KOLs in one motion.
Real-time innovation signals
Catch emerging trends the moment they leave the clinic floor — trap-tox, jawline biostimulators, scar-focused PRF — with provenance back to every post and every injector.
- 3MHOTTrap-tox37 injector posts in 30 days · +412% WoW · LA, MIA, NYC clusters
- 22MWARMBiostim · jawlineOff-label combinations with HA filler trending in AUS, DEN
- 1HMIDPRF · acne scarNurse-led accounts driving 3× engagement vs. board-certified
Site selection in weeks, not months
Run geographic + specialty + velocity filters on the full injector graph. Build site clusters that pass ethics, logistics, and recruitment reality checks — before the first PI call.
Proactive social AE & off-label surveillance
Triage-ready alerts from 4.2M daily signals — off-label language, adverse-event mentions, misuse patterns — with provenance, timestamps, and an MLR-ready audit trail.
- HighOff-label · high-dose toxin3 accounts · 11 posts · flagged to MLR
- MedAE · post-filler nodules5 injectors · 7 patient mentions · 30d window
- LowUnapproved combination · biostim + HA12 accounts · educational trend · monitoring
Three surfaces, one graph. Click anything.
The KOL network, the poaching matrix, and the innovation feed are the same three surfaces Medical Affairs teams open every morning inside Axiogen.
- JUST NOWHOTTrap-toxLA · MIA · NYC · +412%
Toxin injection into trapezius for neckline aesthetic. 41 posts across T1 injectors in 30 days. +412% week-over-week.
- 04m AGOWARMJawline biostim stackingAUS · DEN · SCO · +184%
Off-label combination of PLLA biostimulators with HA filler along mandibular angle. 27 injectors, rapid patient-demand lift.
- 22m AGOMIDPRF · acne scar protocolsCHI · BOS · SF · +96%
Nurse-led accounts driving 3× engagement vs. board-certified on PRF scar revision content. Education content velocity surging.
- 1h AGOMIDSkin-boosters micro-dosingNYC · DC · +71%
Low-dose injectable skin-booster protocols increasingly mentioned alongside maintenance toxin cadence.
Build a trial site list before your competitors even kick off.
Filter by region, treatment area, minimum injector count, and live social velocity. Axiogen builds cluster-ready site maps with provenance on every qualification signal.
- 01Pacific Coast ResearchLos Angeles, CA · 4 PIs · 28 INJ · Toxin + Biostim + Filler92
- 02South Beach Dermatology ResearchMiami, FL · 4 PIs · 26 INJ · Toxin + Biostim + Filler88
- 03Austin Advanced InjectablesAustin, TX · 3 PIs · 22 INJ · Toxin + Biostim + Skin76
- 04Magnolia Aesthetic TrialsAtlanta, GA · 3 PIs · 19 INJ · Biostim + Toxin64
- 05Capital Dermatology NetworkWashington, DC · 3 PIs · 17 INJ · Biostim + Skin62
- 06Beacon Aesthetic TrialsBoston, MA · 2 PIs · 14 INJ · Toxin + Biostim58
- 07Rocky Mountain DermDenver, CO · 2 PIs · 12 INJ · Biostim + Skin54
What scientific affairs teams actually move.
Our MSLs no longer chase yesterday’s KOL list. The DOL graph gives us the Tier-2 voices that will move the field in 18 months.
We caught trap-tox as a signal the week it started surging — not a quarter later in a publication.
Rapid site selection used to be our bottleneck. With Axiogen, we qualify PIs in weeks with real injector volume behind every pick.
Ready to give your scientific affairs team the predictive edge competitors don’t have?
A 15-minute briefing, a live KOL mapping query on your therapeutic area, and a concrete rollout plan across MSL, R&D, ClinOps, and Pharmacovigilance.
MEDICAL · READY TO DEPLOY